ACTRN12618001260213尚未招募未知
Randomized controlled trial of a Mindfulness-Based program for symptoms of depression in people with Multiple Sclerosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Participants will be included if they:
- •1.Have a neurologist-confirmed diagnosis of MS
- •2.18 years old or older
- •3.Currently live in Australia
- •4.Have regular access to the Internet.
- •5.Have sufficient English to complete questionnaires and understand program content in English.
- •6.If taking MS treatment, be on a consistent MS regimen for more than one month with no plans to change this.
- •7.If taking anti-depressant medication, a stable dose for > 8 weeks.
排除标准
- •Participants will be excluded if they:
- •1.Have a comorbid medical condition known to impact on cognition or physical ability
- •2.Have moderate- severe cognitive deficits (<25 on the Telephone Interview for Cognitive Status; TICS).
- •3.Have suicidal intent requiring emergency care
- •4.Have alcohol or drug abuse or dependence
- •5.A psychotic illness or history of bipolar disorder
- •6.Have received consistent psychotherapy within the last 6 months
- •7 . Are pregnant. (Please note that if a participant becomes pregnant during the trial, this will not preclude them from continuing to participate).
研究者
相似试验
进行中（未招募）
1 期
A phase 3 study of parsaclisib plus ruxolitinib in patients with myelofibrosismyelofibrosisMedDRA version: 20.0Level: PTClassification code 10028537Term: MyelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-003415-98-HUIncyte Corporation212
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaEUCTR2017-001903-60-DESanofi-aventis recherche & développement500
进行中（未招募）
1 期
A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder, with Open-Label ExtensioBIPOLAR MANIAEUCTR2004-003781-14-ESJohnson and Johnson Pharmaceutical Research and Development, una división de Janssen-Cilag, S.A
进行中（未招募）
1 期
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)Extensive Stage Small Cell Lung Cancer (ED SCLC)EUCTR2016-003503-64-GBAbbvie Deutschland GmbH & Co. KG748
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT 126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsMedDRA version: 15.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852Alzheimer's DiseaseEUCTR2011-004849-40-DEAbbVie Deutschland GmbH & Co. KG420